Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» AbbVie
AbbVie
Can Gilead Beat AbbVie At Its Own Game?
Seeking Alpha
Thu, 01/29/15 - 07:28 am
Gilead
AbbVie
hepatitis C
Harvoni
Sovaldi
Viekira Pak
Express Scripts
AbbVie Hepatitis C Drug Will Be Focus of Profit Report — Earnings Preview
WSJ Online
Tue, 01/27/15 - 04:32 pm
AbbVie
earnings
Viekira Pak
hepatitis C
Pfizer, Inc. Should Forget AstraZeneca and Buy This Company Instead
Motley Fool
Tue, 01/27/15 - 10:02 am
Pfizer
M&A
AstraZeneca
Shire
AbbVie
Isis Pharmaceuticals
Gilead Sciences, Inc.’s (GILD) Harvoni Prescriptions Drop 1.8%
Bidness Etc.
Mon, 01/26/15 - 11:46 am
Gilead Sciences
Harvoni
hepatitis C
AbbVie
Viekira Pak
Gilead, AbbVie Hep C Price Cuts Seen Hitting Sales
Investors.com
Wed, 01/21/15 - 05:42 pm
Gilead Sciences
AbbVie
hepatitis C
drug pricing
Viekira Pak
Harvoni
Sovaldi
AbbVie Innovation Center Opens at the University of Illinois-Urbana Research Park
Yahoo
Tue, 01/20/15 - 01:49 pm
AbbVie
innovation
AbbVie Inc (ABBV) Expected To Post Single-Digit Growth In Earnings, Revenue For 4Q
Bidness Etc.
Tue, 01/20/15 - 09:30 am
AbbVie
earnings
FirstWord Lists – The drugs that will shape 2015
First Word Pharma
Mon, 01/19/15 - 04:14 pm
Harvoni
Viekira Pak
Gilead Sciences
AbbVie
alirocumab
evolocumab
Amgen
Regeneron
Sanofi
Opdivo
Keytruda
Merck
Bristol-Myers Squibb
Novartis
CTL019
Zarxio
Pfizer
palbociclib
Saxenda
Trulicity
Afrezza
MannKind
Eli Lilly
Novo Nordisk
LCZ696
Toujeo
Breo Ellipta
GED-0301
Celgene
BiogenIdec
AbbVie Strikes Hepatitis C Discount Deal With AIDS Drug Programs
Bloomberg
Mon, 01/19/15 - 12:06 pm
AbbVie
hepatitis C
AIDS
HIV
Viekira Pak
Aetna backs Gilead's hepatitis C treatment, gets discount
Reuters
Sat, 01/17/15 - 11:03 am
Aetna
Gilead Sciences
hepatitis C
AbbVie
Sovaldi
Harvoni
Viekira Pak
Abandonment rates indicate room in the anti-TNF market
Medical Marketing and Media
Fri, 01/16/15 - 08:52 am
anti-TNF
JNJ
Remicade
Humira
AbbVie
Biogen Idec
AbbVie’s hepatitis C drug gets European approval for sale
Marketwatch
Fri, 01/16/15 - 08:45 am
AbbVie
hepatitis C
Europe
Viekira Pak
Receptos Shopping For A Partner With Strong Data In Hand
Seeking Alpha
Thu, 01/15/15 - 12:05 pm
Receptos
AbbVie
Biogen Idec
JNJ
Novartis
RPC1063
ulcerative colitis
multiple sclerosis
Insight - Big Pharma faces up to new price pressure from aggressive insurers
Yahoo/Reuters
Thu, 01/15/15 - 09:02 am
insurance
Big Pharma
drug pricing
Express Scripts
AbbVie
Gilead Sciences
AstraZeneca
Eli Lilly
Aetna CEO says no decision yet on how to cover hepatitis C drugs
Yahoo/Reuters
Wed, 01/14/15 - 09:01 am
Aetna
hepatitis C
AbbVie
Gilead Sciences
AbbVie wins U.S. approval for Parkinson's treatment
Yahoo/Reuters
Mon, 01/12/15 - 08:54 am
AbbVie
FDA
Parkinson's Disease
Duopa
Neurocrine Biosciences Starts A Data-Rich Year On The Right Foot
Seeking Alpha
Fri, 01/9/15 - 07:02 pm
Neurocrine Biosciences
AbbVie
Elagolix
Biotech Investors Guide and Preview to the J.P. Morgan Healthcare Conference Part 2
TheStreet.com
Fri, 01/9/15 - 09:18 am
biotech
JPMHC 2015
Juno Therapeutics
AbbVie
MannKind
EXACT Sciences
NewLink Genetics
Biotech’s Price Wars Are Just Beginning
Bloomberg
Fri, 01/9/15 - 08:01 am
biotech
AbbVie
Gilead Sciences
drug pricing
hepatitis C
AbbVie raises 2015 outlook
Marketwatch
Thu, 01/8/15 - 10:18 pm
AbbVie
Pages
« first
‹ previous
…
59
60
61
62
63
64
65
66
67
…
next ›
last »